CLINICAL TRIAL

Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy & (Neuro)Cognitive Mechanisms

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: ClinicalTrials.gov
Date: 2024-08-07
Source: ClinicalTrials.gov
DOI: Unavailable
PubMed: Unavailable

Authors

Brugmann University Hospital

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Addiction Neuroplasticity Mechanism of Action Biomarkers Clinical Trial Safety Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in LifeClinicalTrials.gov · 2026-08-17 Psychedelics and Psychedelic-Assisted Psychotherapy.The American journal of psychiatry · 2020-05-01 Psychedelics and Psychedelic-Assisted Psychotherapy.Focus (American Psychiatric Publishing) · 2021-01-01